137 related articles for article (PubMed ID: 36052438)
1. LPS preconditioning of MSC-CM improves protection against hypoxia/reoxygenation-induced damage in H9c2 cells partly via HMGB1/Bach1 signalling.
Wang D; Xie Y; Peng HQ; Wen ZM; Ying ZY; Geng C; Wu J; Lv HY; Xu B
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1319-1333. PubMed ID: 36052438
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide-pretreated mesenchymal stem cell-conditioned medium optimized with 10 kDa filter attenuates the injury of H9c2 cardiomyocytes in a model of hypoxia/reoxygenation.
Wang D; Wen JY; Wu D; Ying ZY; Wen ZM; Peng HQ; Geng C; Feng YB; Sui ZG; Lv HY; Wu J; Xu B
Can J Physiol Pharmacol; 2022 Jul; 100(7):651-664. PubMed ID: 35533248
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharides protect mesenchymal stem cell against cardiac ischemia-reperfusion injury by HMGB1/STAT3 signaling.
Wen JY; Peng HX; Wang D; Wen ZM; Liu YT; Qu J; Cui HX; Wang YY; DU YL; Wang T; Geng C; Xu B
J Geriatr Cardiol; 2023 Nov; 20(11):801-812. PubMed ID: 38098470
[TBL] [Abstract][Full Text] [Related]
4. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway.
Yang Y; Chen QH; Liu AR; Xu XP; Han JB; Qiu HB
Stem Cell Res Ther; 2015 Dec; 6():250. PubMed ID: 26674641
[TBL] [Abstract][Full Text] [Related]
5. [Astragaloside Ⅳ regulates Nrf2/Bach1/HO-1 signaling pathway and inhibits H9c2 cardiomyocyte injury induced by hypoxia-reoxygenation].
Yang P; Zhou YP; Chang XC; Wang F; Li GW
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2331-2337. PubMed ID: 31359660
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 induces apoptosis and EMT in association with increased autophagy following H/R injury in cardiomyocytes.
Ouyang F; Huang H; Zhang M; Chen M; Huang H; Huang F; Zhou S
Int J Mol Med; 2016 Mar; 37(3):679-89. PubMed ID: 26847839
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine alleviates hypoxia/reoxygenation-induced apoptosis in neonatal mice cardiomyocytes via up-regulating HMGB1 expression to promote autophagy.
Lu S; Yu L; Liu H
J Recept Signal Transduct Res; 2021 Apr; 41(2):170-179. PubMed ID: 32757698
[TBL] [Abstract][Full Text] [Related]
9. Wnt11 preserves mitochondrial membrane potential and protects cardiomyocytes against hypoxia through paracrine signaling.
Li HX; Lin J; Jiang B; Yang XJ
J Cell Biochem; 2020 Feb; 121(2):1144-1155. PubMed ID: 31463993
[TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism.
Crisostomo PR; Wang Y; Markel TA; Wang M; Lahm T; Meldrum DR
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C675-82. PubMed ID: 18234850
[TBL] [Abstract][Full Text] [Related]
11. GATA-4 protects against hypoxia-induced cardiomyocyte injury: effects on mitochondrial membrane potential.
Li HX; Zhou YF; Zhao X; Jiang B; Yang XJ
Can J Physiol Pharmacol; 2014 Aug; 92(8):669-78. PubMed ID: 25000170
[TBL] [Abstract][Full Text] [Related]
12. Isorhamnetin protects against hypoxia/reoxygenation-induced injure by attenuating apoptosis and oxidative stress in H9c2 cardiomyocytes.
Zhao TT; Yang TL; Gong L; Wu P
Gene; 2018 Aug; 666():92-99. PubMed ID: 29730426
[TBL] [Abstract][Full Text] [Related]
13. miR-708 affords protective efficacy in anoxia/reoxygenation-stimulated cardiomyocytes by blocking the TLR4 signaling via targeting HMGB1.
Zhang S; Wang Y; Wang P; Xuan J
Mol Cell Probes; 2020 Dec; 54():101653. PubMed ID: 32866662
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury.
Chu X; Xu B; Gao H; Li BY; Liu Y; Reiter JL; Wang Y
Stem Cells Dev; 2019 May; 28(9):620-631. PubMed ID: 30808255
[TBL] [Abstract][Full Text] [Related]
15. [The role and mechanism of mesenchymal stem cell in modulating human pulmonary microvascule endothelial cell permeability via paracrine hepatocyte growth factor].
Chen QH; Zheng RQ; Wang HL; Yang Y; Qiu HB
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Nov; 40(11):855-858. PubMed ID: 29320834
[No Abstract] [Full Text] [Related]
16. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence.
Zheng H; Liang X; Han Q; Shao Z; Zhang Y; Shi L; Hong Y; Li W; Mai C; Mo Q; Fu Q; Ma X; Lin F; Li M; Hu B; Li X; Zhang Y
J Nanobiotechnology; 2021 Oct; 19(1):332. PubMed ID: 34674708
[TBL] [Abstract][Full Text] [Related]
17. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Wang Z; Tang D; Luo Y; Xiong Z
Stem Cell Res Ther; 2019 Jan; 10(1):46. PubMed ID: 30683144
[TBL] [Abstract][Full Text] [Related]
18. MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1.
Chen ZX; He D; Mo QW; Xie LP; Liang JR; Liu L; Fu WJ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4440-4450. PubMed ID: 32373982
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF).
Wang H; Zheng R; Chen Q; Shao J; Yu J; Hu S
Stem Cell Res Ther; 2017 Sep; 8(1):211. PubMed ID: 28969681
[TBL] [Abstract][Full Text] [Related]
20. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury.
Feng Y; Yang Q; Xu J; Qian G; Liu Y
Exp Mol Pathol; 2008 Dec; 85(3):214-22. PubMed ID: 18952078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
